Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
$43.46M
Dr. Lishan Aklog M.D.
New York, NY
Oct 14, 2021
-0.67
$-1.21
1.22
1.34
-254,695.08%
-0.03
0.00
3.61
71.68
1.22
-4,753.88%
-8,921.37%
Similar stocks (13)
Integer Holdings Corporation
ITGR
Inari Medical, Inc.
NARI
OrthoPediatrics Corp.
KIDS
Orthofix Medical Inc.
OFIX
Paragon 28, Inc.
FNA
IRadimed Corporation
IRMD
Surmodics, Inc.
SRDX
ClearPoint Neuro, Inc.
CLPT
Pulmonx Corporation
LUNG
NeuroPace, Inc.
NPCE
CVRx, Inc.
CVRX
Electromed, Inc.
ELMD
Beyond Air, Inc.
XAIR
ETF Exposure (5)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
Integer Holdings Corporation
ITGR
Inari Medical, Inc.
NARI
OrthoPediatrics Corp.
KIDS
Orthofix Medical Inc.
OFIX
Paragon 28, Inc.
FNA
IRadimed Corporation
IRMD
Surmodics, Inc.
SRDX
ClearPoint Neuro, Inc.
CLPT
Pulmonx Corporation
LUNG
NeuroPace, Inc.
NPCE
CVRx, Inc.
CVRX
Electromed, Inc.
ELMD
Beyond Air, Inc.
XAIR
ETF Exposure (5)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%